Form 8.5 (EPT/RI) - Spire Healthcare Group plc

Summary by AI BETAClose X

Spire Healthcare disclosed that exempt principal trader J.P. Morgan Securities Plc executed purchases of 1,601,609 1p ordinary shares at £2.4706–£2.4850 and sales of 4,034,776 shares at £2.4800–£2.4850 on 06 November 2026; cash-settled equity swaps included a 2,607,163-unit decrease in short exposure and other swap adjustments that produced a net increase in long exposure of c.2,487,960 reference shares, leaving an overall net acquisition of approximately 54,793 shares after combining outright trades and swaps, with the disclosure filed on 09 November 2026.

Disclaimer*

UK 100

Latest directors dealings